Dr. Charles Gombar is deputy director, strategy and product development for the HIV program where he helps guide the overall HIV strategy for the organization and guides product development investments and activities with key partners to introduce new interventions for HIV prevention and treatment.
Prior to joining the foundation, Charles spent over 30 years in R&D in the pharmaceutical industry in companies such as SmithKline Beecham, Sterling Winthrop, Wyeth, Pfizer, and Endo. Much of his time in the industry was spend leading cross-functional product development teams. Products brought successfully to market include Coreg®, Plavix®, Effexor XR®, Sonata®, and Relistor®. He also served as Associate Director for Drug Metabolism and Pharmacokinetics at SmithKline Beecham.
Charles received his undergraduate degree in Chemistry from Pace University and his Ph.D. in Pharmacology from the Albany Medical College.